首页> 外文期刊>International Journal of Clinical Medicine >Correlation of Hormonal Receptors Estrogen Receptor, Progesterone Receptor and Her-2/Neu with Tumor Characteristics in Breast Carcinoma: Study of 100 Consecutive Cases
【24h】

Correlation of Hormonal Receptors Estrogen Receptor, Progesterone Receptor and Her-2/Neu with Tumor Characteristics in Breast Carcinoma: Study of 100 Consecutive Cases

机译:乳腺癌荷尔蒙受体雌激素受体,孕激素受体和Her-2 / Neu与肿瘤特征的相关性研究:连续100例研究

获取原文
           

摘要

Introduction-Breast cancer is the most common cancer and leading cause of death in women. In India, its incidence is rapidly rising over last few decades. Present study is aimed to study the pattern of expression of hormonal receptors and Her-2eu in invasive breast carcinoma and to correlate estrogen receptor (ER), progesterone receptor (PR) and Her-2eu expressions with various clinicopathological parameters. Material and methods: The present study was carried out in Department of Pathology, S.C.B. Medical College, Cuttack in the year 2013 taking consecutive 100 cases. Routine H&E staining for histological diagnosis and IHC analysis for ER, PR and Her 2eu was carried out in all 100 cases of breast malignancies. Results: 99% of cases are invasive breast carcinoma, not otherwise specify (IDC-NOS). The age ranges from 23 years to 72 years. Majority of tumors are of grade 2 (70%) followed by grade 3 (30%). ER PR and Her-2eu expression are seen in 45%, 35% and 30% respectively. Triple negative cases comprise 35%. Higher number of grade 2 tumor shows ER, PR positivity as compared to grade 3 tumors. Her-2eu expression does not show any significant correlation with age or lymph node status of the patient. Conclusion: ER and PR expression in breast cancers in the current study are found to be comparable to the findings of other authors, but the frequency of HER-2eu expression is slightly higher. Significant correlation is observed between hormonal receptor status and the grade of the tumor. Inverse relationship is found between Her-2eu expression and ER, PR receptor status. Her-2eu expression is increased with size and high grade of tumor.
机译:简介-乳腺癌是女性中最常见的癌症和主要死因。在印度,近几十年来其发病率迅速上升。本研究旨在研究浸润性乳腺癌中激素受体和Her-2 / neu的表达模式,并将雌激素受体(ER),孕激素受体(PR)和Her-2 / neu的表达与各种临床病理参数相关联。材料和方法:本研究是在S.C.B.病理学系进行的。 Cuttack医学院在2013年连续收治100例。所有100例乳腺恶性肿瘤均进行常规H&E染色,以进行组织学诊断和ER,PR和Her 2 / neu的IHC分析。结果:99%的病例是浸润性乳腺癌,未另作说明(IDC-NOS)。年龄从23岁到72岁不等。多数肿瘤为2级(70%),其次为3级(30%)。 ER PR和Her-2 / neu表达分别见于45%,35%和30%。三重阴性病例占35%。与3级肿瘤相比,更多的2级肿瘤显示ER,PR阳性。 Her-2 / neu表达与患者的年龄或淋巴结状况无显着相关性。结论:本研究发现乳腺癌中的ER和PR表达与其他作者的研究结果相当,但HER-2 / neu表达的频率略高。在激素受体状态与肿瘤等级之间观察到显着相关性。在Her-2 / neu表达与ER,PR受体状态之间存在反比关系。 Her-2 / neu表达随肿瘤的大小和高度分级而增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号